How protein degradation affects biological timing in plants
Protein degradation mechanisms that regulate daily and seasonal timing
This study looks at how certain proteins in plants, especially Arabidopsis, help them keep track of time throughout the day and year, which is important for their growth and survival.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11099097 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which protein degradation influences the circadian clock and seasonal timing in plants, particularly using Arabidopsis as a model organism. It focuses on understanding how these processes help plants synchronize their biological functions with daily and seasonal environmental changes. The research aims to explore the role of E3 ubiquitin ligases in regulating these timing mechanisms, which could provide insights into how plants measure daylength and adapt their physiology accordingly.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals interested in plant biology, agriculture, or those affected by agricultural practices impacted by seasonal changes.
Not a fit: Patients who are not involved in agricultural practices or do not have an interest in plant biology may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of plant biology, potentially leading to improved agricultural practices and crop resilience to environmental changes.
How similar studies have performed: Previous research has shown success in understanding circadian rhythms and protein degradation in model organisms, suggesting that this approach could yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Gendron, Joshua Martin — Yale University
- Study coordinator: Gendron, Joshua Martin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.